Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asenapine for Bipolar Depression
NCT01807741Phase 2Terminated
- Sponsor
- University of Cincinnati
- Start
- Sep 2013
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of asenapine in bipolar disorder (BD), sponsored by University of Cincinnati. Started Sep 2013; status: terminated.
02
Drugs
asenapine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT01807741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01807741.